Observed arrival · 2026-11-06
GxRadar keeps a ledger of generic-drug prices and disruptions
An independent tracker combines FDA shortage, recall, and approval records with CMS price histories for common generic drugs.
○Open
⊠Login
$Paid
†Ads
✦Pretty
●Pro
◎Niche
◉Human
⚑Risk
ƒJS
- For
- Pharmacists, generic-drug researchers, and shortage watchers
- Worth noticing
- Its index tracks 43 generics using CMS NADAC acquisition costs, explicitly not patient prices.
Field notes
The index is based on monthly per-unit NADAC figures for 43 generics, compared with January 2014; the site describes the combined measure as a geometric mean. Individual examples show prices moving in opposite directions: the page reports a long decline for doxycycline and a rise for furosemide. Its articles are grouped by subject and described as including inline citations to primary sources.
Observed signals
Read the marks
Editorial observations of this landing page, not a rating.
○OpenPublic substance visible
✦PrettyNotable craft visible
●ProPolished or operationally mature
◎NicheUnusually specific use
◉HumanPersonal, local, civic, or handmade
ƒJavaScriptBrowser-side code central
One card from the complete issue